We noticed JavaScript is turned off in your browser settings. For a better viewing experience, enable JavaScript. If you're unsure of how to do this, click here to download a new browser.

Cancer
Clinical Trials

For Information Call

1-310-423-2133

or

cancer.trial.info@cshs.org

Find a Clinical Trial by Drug

Adult Cancers
Childhood Cancers
Doctor
Drug
Phase

New studies open frequently, please check back for updates

New studies open frequently, please check back for updates

The following physicians have trials which are currently recruiting patients. If you do not see the doctor you are searching for, please call 310-423-2133 for more information.

Back to Protocols

Doctor:

Protocol Summary

Study No.	TYR-219-01
Principal Investigator	Gutierrez, Rodolfo
Phase	I/II
Study Name	A Phase 1/2 Study with Open-Label, Dose Escalation Phase Followed by Single-Arm Expansion at the Maximum Tolerated Dose to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of NT219 Injection alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced solid tumors and Head and Neck cancer (IRB#907)
Cancer Type	Anus Brain and Nervous System Breast Cervix Colon Endometrium Esophagus Eye and Orbit Head and Neck Hodgkin's Lymphoma Ill-Defined Sites Kaposi's sarcoma Kidney Leukemia Liver Lung Melanoma Ovary Pancreas Prostate Rectum Sarcoma Small Intestine Stomach Thyroid Urinary Bladder
Study Summary
Study Site(s)	The Angeles Clinic and Research Institute
Key Eligibility	ClinicalTrials.gov

Researchers test an experimental drug or treatment in a small group of people (20-80), to evaluate its safety and identify side effects. Often these trials are not disease specific and may include more than one type of cancer.

The experimental drug or treatment is administered to a larger group of people (100-300) to determine its effectiveness and to further evaluate its safety.

The experimental drug or treatment is administered to larger groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it with standard or equivalent treatment, and collect information that will allow the experimental drug or treatment to be used safely.